TCAF ETF Analysis: T. Rowe Price Capital | NYSE
Large Blend | NYSE, USA | Market Cap: 7.880m USD | 12M Return: 12.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 22.0M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
T. Rowe Price Capital Appreciation Equity ETF (TCAF) is a U.S.-listed, non-diversified ETF that invests at least 80% of its net assets in equity securities. The fund typically focuses on large-capitalization U.S. companies, although it is permitted to purchase stocks of any size.
Portfolio exposure may be concentrated in specific sectors, notably information technology and healthcare-two of the largest segments of the U.S. equity market, encompassing industries such as software, semiconductors, pharmaceuticals, and medical devices. Launched on June 14, 2023, TCAF is classified as a Large Blend fund.
- Large cap US equities rally lifts portfolio NAV
- Information technology sector concentration drives fund performance
- T. Rowe Price ETF inflows expand AUM and fee revenue
As of July 28, 2026, the stock is trading at USD 40.86 with a total of 452,295 shares traded. Over the past week, the price has changed by -0.56%, over one month by +0.10%, over three months by +3.89% and over the past year by +12.14%.
Current recommended Stop Loss: 40.30 (which is 1.4% or 1.5 ATR below the current price).
T. Rowe Price Capital has no consensus analysts rating.